Exelon (Exelon) Change In Receivables

: $-37 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

Exelon's change in receivables for the quarter that ended in Dec. 2023 was $-119 Mil. It means Exelon's Accounts Receivable increased by $119 Mil from Sep. 2023 to Dec. 2023 .

Exelon's change in receivables for the fiscal year that ended in Dec. 2023 was $-37 Mil. It means Exelon's Accounts Receivable increased by $37 Mil from Dec. 2022 to Dec. 2023 .

Exelon's Accounts Receivable for the quarter that ended in Dec. 2023 was $2,342 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Exelon's Days Sales Outstanding for the three months ended in Dec. 2023 was 39.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Exelon's liquidation value for the three months ended in Dec. 2023 was $-73,189 Mil.

Exelon Change In Receivables Historical Data

The historical data trend for Exelon's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exelon Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-243.00

697.00

-703.00

-1,222.00

-37.00

Exelon Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables																-173.00	106.00	281.00	-305.00	-119.00

Exelon Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-37 Mil.

Exelon (NAS:EXC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Exelon's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2342	/	5367	*	91
=	39.82

2. In Ben Graham's calculation of liquidation value, Exelon's accounts receivable are only considered to be worth 75% of book value:

Exelon's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	445	-	75791	+	0.75 * 2342	+	0.5 * 801
=	-73,189

Exelon Change In Receivables Related Terms

Thank you for viewing the detailed overview of Exelon's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Exelon (Exelon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Regulated » Exelon Corp (NAS:EXC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

EXC:Mexico 1EXC:Italy PEO:Germany PEO:Germany PEO:Germany E1XC34:Brazil

Address

10 South Dearborn Street, 54th Floor, P.O. Box 805379, Chicago, IL, USA, 60680-5379

Website

https://www.exeloncorp.com

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.

Executives

Anna Richo	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Robert A Kleczynski	officer: SVP & Corp Controller	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Matthew C Rogers	director	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Charisse R Lillie	director	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Carim V Khouzami	officer: CEO of BGE	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Jeanne M Jones	officer: EVP & CFO	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
John Tyler Anthony	officer: CEO Pepco Holdings LLC	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Trpik Joseph R Jr	officer: SVP & Corp. Controller	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
William P Bowers	director	600 NORTH 18TH STREET, BIN 15N-8170, BIRMINGHAM AL 35203
Gayle Littleton	officer: EVP & General Counsel	10 S. DEARBORN ST., 52ND FLOOR SE, CHICAGO IL 60603
Calvin Jr Butler	officer: Sr EVP & CEO Exelon Utilities	10 SOUTH DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
James Mchugh	officer: EVP & Chief Commercial Officer	10 S DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Joseph Dominguez	officer: CEO, ComEd	10 SOUTH DEARBORN STREET, CHICAGO IL 60603
Joseph Nigro	officer: Sr. EVP & Chief Fin. Officer	10 S. DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603
Christopher M. Crane	director, officer: President and CEO	10 SOUTH DEARBORN STREET, 54TH FLOOR, CHICAGO IL 60603